Alliance Pharma Share Discussion Threads

[5070481] 09/9/2010 22:28

RHPS tipped again as a buy upto 39p.

[deucetoace] 09/9/2010 21:21

I didn't think they sold - total figure was the same - just moved the holdings about so they were holding more indirectly. Is that not the case?

[cfro] 09/9/2010 18:33

Incidently, Aviva selling....so who's buying ? Slater or Wray ?

[montyhedge] 09/9/2010 18:21

I agree, overpriced.

[cfro] 09/9/2010 18:20

I dont believe the current forecast either. Reckon they will be upped massively in coming weeks and give us the all important PEG factor.

[stegrego] 09/9/2010 13:03

I dont believe these are pricey at all.
Nor do i believe the forecasts.....

[stegrego] 09/9/2010 13:00

Alliance Pharma

Our view: Buy

Share price: 37.75p (+1p)

Rarely are we able to say in this column, and especially so over the last few years, that a company's first-half profit jumped by 166 per cent.

Alliance Pharma, an Alternative Investment Market-listed company, makes its money by buying, marketing and distributing a large range of licensed prescription medicines. And, on the strengthen of yesterday's numbers, the strategy appears to be working. For investors wanting to back small-cap pharmaceuticals companies, picking the best one can be akin to a game of pinning the tail on the donkey. For every success like Alliance, 10 such groups often burn shareholders' cash without return.

As such, there must be a coherent argument to suggest that when one finds a good stock in the sector, one should stick with it. A share price jump of more than 100 per cent in the last 12 months, and a confident outlook statement from Alliance yesterday, should be enough to convince backers that the company is one of the industry's safe picks.

But of course, there is a cloud to every silver lining. The share price gains have left the group looking a little pricey on a 2011 forecast multiple of 12.2 times. The yield of 1.2 per cent is also unimpressive, although the company would rightly argue that it is rare to find similar groups making any payment at all. The numbers prove that Alliance is getting it right, and while the stock is expensive, it is one of the outstanding picks in the sector. Buy.

[miavoce] 09/9/2010 12:22

I believe that the fall in the forecast is deue to the timing of the payment for a contract which is bi annual, although I can't remember what it was - details were in SCSW write up.

[supersturrock] 09/9/2010 12:11

Thanks Deu.

[deucetoace] 09/9/2010 11:59

The forecasts are concerned about the competition for Deltacortril which is mentioned in the interim report and is likely to come in the next financial year. Sales of this and hence profits from this will fall. Given the growth in other areas of the business the size of the overall fall is looking rather pessimistic.

[supersturrock] 09/9/2010 11:54

Hello. Propsective newbie here. How come Digital Look is showing broker forecasts of lower profits & earnings in 2011. What am I missing ?

[shauney2] 09/9/2010 08:54

From the Independent

[5070481] 08/9/2010 22:20

I think the market is going to take a bit of time to relaise that the reservations that were mentioned in teh outlook should not fundamentally impact the prospects. THey have great market presence and an impressive ability of picking good products for the portfolio.

Still sticking to my 60p target.

[cfro] 08/9/2010 19:13

Record set of figures.

Nice safe share to hold imo. Broker upgrades will surely follow imo.

[silverfern] 08/9/2010 18:45

contains a really useful company presentation from APril. Deltacotril is 19% sales in 2009. Seems to me APH know their market, know how to buy and have a diversified portfolio of products and increasingly territories to drive growth.

[melody9999] 08/9/2010 15:53

Well I've topped up in anticipation of broker upgrades and positive newsflow. No reason the share price should not continue in the next few months exactly the same direction as the graph for the past 18 months. Don't need the volatility - just a safe bet steady increase will do me!

[daicaprice] 08/9/2010 15:10

Hard to believe we haven't raced through 40p today after those figures,way undervalued now.

DC

[beerbandit] 08/9/2010 15:06

"Assuming no growth in second half? otherwise pe would be more like" Agree totally but dont want to be accused of ramping!

[deucetoace] 08/9/2010 12:26

Well surely the concern is next year with the competitor for Deltacortril coming in. The market is looking forward to that to work out what a sensible PE should be.

[hirschnathan] 08/9/2010 12:24

"Superb reults APH now trading on a forward PE of less than 8!"

Assuming no growth in second half? otherwise pe would be more like 6

[beerbandit] 08/9/2010 11:09

Superb reults APH now trading on a forward PE of less than 8!

[allstar_07] 08/9/2010 09:28

100k through at 39p

[daicaprice] 08/9/2010 08:36

The little shake for the top up as expected, and then through 40p.

DC

[silverfern] 08/9/2010 08:11

THey also sell into New Zealand and China- a bit of balance. I like this bit given the success of the Cambridge acquisition: "We intend to continue adding brands that fit our strategy, and are well placed to fund further acquisitions when we find the right deals."